Kessler Investment Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,165	Closed	-$122K	–	185
2022 Q1	$122K	Hold	5,165	–	–	0.07%	85
2021 Q4	$177K	Hold	5,165	–	–	0.1%	81
2021 Q3	$92K	Buy	+5,165	New	+$92K	0.07%	92